Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |